209 related articles for article (PubMed ID: 18491888)
1. Core trees and consensus fragment sequences for molecular representation and similarity analysis.
Lounkine E; Bajorath J
J Chem Inf Model; 2008 Jun; 48(6):1161-6. PubMed ID: 18491888
[TBL] [Abstract][Full Text] [Related]
2. Bioisosteric similarity of molecules based on structural alignment and observed chemical replacements in drugs.
Krier M; Hutter MC
J Chem Inf Model; 2009 May; 49(5):1280-97. PubMed ID: 19402687
[TBL] [Abstract][Full Text] [Related]
3. Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations.
Batista J; Bajorath J
J Chem Inf Model; 2007; 47(1):59-68. PubMed ID: 17238249
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2D fingerprint methods for multiple-template similarity searching on compound activity classes of increasing structural diversity.
Tovar A; Eckert H; Bajorath J
ChemMedChem; 2007 Feb; 2(2):208-17. PubMed ID: 17143917
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme.
Xue L; Godden JW; Stahura FL; Bajorath J
J Chem Inf Comput Sci; 2003; 43(4):1151-7. PubMed ID: 12870906
[TBL] [Abstract][Full Text] [Related]
6. Fragment formal concept analysis accurately classifies compounds with closely related biological activities.
Krüger F; Lounkine E; Bajorath J
ChemMedChem; 2009 Jul; 4(7):1174-81. PubMed ID: 19384901
[TBL] [Abstract][Full Text] [Related]
7. RelACCS-FP: a structural minimalist approach to fingerprint design.
Hu Y; Lounkine E; Batista J; Bajorath J
Chem Biol Drug Des; 2008 Nov; 72(5):341-9. PubMed ID: 19012570
[TBL] [Abstract][Full Text] [Related]
8. Mapping of activity-specific fragment pathways isolated from random fragment populations reveals the formation of coherent molecular cores.
Lounkine E; Batista J; Bajorath J
J Chem Inf Model; 2007; 47(6):2133-9. PubMed ID: 17939652
[TBL] [Abstract][Full Text] [Related]
9. Substructure mining using elaborate chemical representation.
Kazius J; Nijssen S; Kok J; Bäck T; Ijzerman AP
J Chem Inf Model; 2006; 46(2):597-605. PubMed ID: 16562988
[TBL] [Abstract][Full Text] [Related]
10. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
Auer J; Bajorath J
J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
[TBL] [Abstract][Full Text] [Related]
11. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
[TBL] [Abstract][Full Text] [Related]
12. Determination and mapping of activity-specific descriptor value ranges for the identification of active compounds.
Eckert H; Bajorath J
J Med Chem; 2006 Apr; 49(7):2284-93. PubMed ID: 16570925
[TBL] [Abstract][Full Text] [Related]
13. A scoring scheme for discriminating between drugs and nondrugs.
Sadowski J; Kubinyi H
J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
[TBL] [Abstract][Full Text] [Related]
14. Similarity search profiles as a diagnostic tool for the analysis of virtual screening calculations.
Xue L; Godden JW; Stahura FL; Bajorath J
J Chem Inf Comput Sci; 2004; 44(4):1275-81. PubMed ID: 15272835
[TBL] [Abstract][Full Text] [Related]
15. Target family-directed exploration of scaffolds with different SAR profiles.
Hu Y; Bajorath J
J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
[TBL] [Abstract][Full Text] [Related]
16. Predictive activity profiling of drugs by topological-fragment-spectra-based support vector machines.
Kawai K; Fujishima S; Takahashi Y
J Chem Inf Model; 2008 Jun; 48(6):1152-60. PubMed ID: 18533712
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of a novel class-directed 2D fingerprint to search for structurally diverse active compounds.
Eckert H; Bajorath J
J Chem Inf Model; 2006; 46(6):2515-26. PubMed ID: 17125192
[TBL] [Abstract][Full Text] [Related]
18. In silico screening of drug databases for TSE inhibitors.
Lorenzen S; Dunkel M; Preissner R
Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
[TBL] [Abstract][Full Text] [Related]
19. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
Vogt M; Bajorath J
Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
[TBL] [Abstract][Full Text] [Related]
20. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
